ClinicalTrials.gov
public full text
Public Domain
The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study
This study is an Investigator initiated, randomized, multicenter, double-blind, placebo-control study. The aim of this study is to evaluate the safety and efficiency of Sirolimus for primaty antiphospholipid syndrome patients at week 24 and week 48.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis#866044
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients#1103083
- Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples#869994
- Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis#1096458
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R#899821
Record · ID 838525
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive